ArticleBreast cancer research and treatment2020

Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.

Mary D Chamberlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.